Abstract: New bismuth(III) bromine compounds of the heterocyclic thioamides were prepared and structurally characterized. (5) complexes (MMI: 2-mercapto-1-methylimidazole, MBZIM: 2-mercaptobenzimidazole, tHPMT: 2-mercapto-3,4,5,6-tetrahydro-pyrimidine, PYT: 2-mercaptopyridine and MBZT: 2-mercaptobenzothiazole). The complexes 1-5 were characterized by melting point (m.p.), elemental analysis (e.a.), molar conductivity, Fourier-transform infrared (FT-IR), Fourier-transform Raman (FT-Raman), nuclear magnetic resonance ( 1 H and 13 CNMR) spectroscopy, UV-Vis spectroscopy and thermogravimetric-differential thermal analysis (TG-DTA). The molecular structures of 1-5 were determined by single-crystal X-ray diffraction. Complex 2 is a first ionic monomuclear octahedral bismuth(III) bromide, while the complexes 1, 3-5 are the first examples of dinuclear bismuth(III) bromide derivatives. Complexes 1-5 were evaluated in terms of their in vitro cytotoxic activity against human adenocarcinoma breast (MCF-7) and cervix (HeLa) cells. The toxicity on normal human fetal lung fibroblast cells (MRC-5) was also evaluated. Moreover, the complexes 1-5 and free heterocyclic thioamide ligands were studied upon the catalytic peroxidation of the linoleic acid by the enzyme lipoxygenase (LOX).
Introduction
Presently, the medicinal application of bismuth(III) compounds is focused on the antibacterial and anticancer metallodrugs (Yang and Sun, 2007) . Thus, bismuth(III) halide ditihocarbamate complexes of the general formula BiX n (S 2 CNR 2 ) 3-n , (n = 0, 1 and 2, X=Cl, Br or I) have proven to display extremely strong cytotoxic activity against human breast adenocarcinoma (MCF-7) cells, while their IC 50 values lie in the range of nanomolar (Ozturk et al., 2014a,b; Arda et al., 2016) . Bismuth(III) thiosemicarbazone complexes also showed effective cytotoxic activity against cancerous cell lines (Li et al., 2012a,b; Zhang et al., 2014) .
The enzyme lipoxygenase (LOX) participates in the mechanism of inflammation, catalyzing the oxidation of arachidonic acid to leukotrienes in an essential mechanism for cell life (Xanthopoulou et al., 2008; Ozturk et al., 2010; Poyraz et al., 2011) . LOX has been investigated as a potent target for the development of new metallodrugs against cancerous cells as it has been associated with the antiproliferative activity by the induction of apoptosis in tumor cells (Poyraz et al., 2011) .
In the course of our studies towards the development of effective chemotherapeutics agents (Hadjikakou et al., 2005; Ozturk et al., 2007 Ozturk et al., , 2009 Ozturk et al., , 2010 Ozturk et al., , 2011 Ozturk et al., , 2012a Ozturk et al., ,b, 2013 Ozturk et al., , 2014a Ozturk et al., ,b, 2017 Xanthopoulou et al., 2008; Balas et al., 2011; Poyraz et al., 2011; Shpakovsky et al., 2012; Banti et al., 2016; Urgut et al., 2016a,b; Yarar et al., 2018) we describe here the synthesis and characterization of the complexes {[BiBr 2 (μ 2 -Br) ( (5) using the heterocyclic thioamide ligands (Scheme 1). In order to rationalize the hindrance due to steric effects and the electronic factors that govern the biological activity, many compounds of the main group of metal ions (Sn(IV), Sb(III/IV), Bi(III) etc.) (Hadjikakou et al., 2005; Ozturk et al., 2007 Ozturk et al., , 2009 Ozturk et al., , 2010 Ozturk et al., , 2011 Ozturk et al., , 2012a Ozturk et al., ,b, 2013 Ozturk et al., , 2014a Ozturk et al., ,b, 2017 Xanthopoulou et al., 2008; Balas et al., 2011; Poyraz et al., 2011; Shpakovsky et al., 2012; Banti et al., 2016; Urgut et al., 2016a,b; Yarar et al., 2018) with various types of ligands, such as Thioamides, Dithiocarbametes, the Non-Steroidal Anti-inflammatory Drugs (NSAID), aspirin, salicylic acid, naproxen, etc. were synthesized and characterized. The present manuscript describes the recent results obtained in bismuth(III) bromide. These results are compared with those previously reported from our group in relation with the drug cisplatin, which is in clinical use (Table 2 ). Conclusions will be attempted upon changing either the halogen counter anion (Cl, Br and I) or the ligand type (thioamides, dithiocarbamates). Among thioamides, the electronic effect is arising from thiourea derivatives with 5-member ring imidazole, benzimidazole and benzothiazle and 6-member ring tetrahydro pyrimidine and pyridine (Scheme 1). The in vitro cytotoxicity of the compounds was tested against the cancerous and noncancerous cell lines. The antioxidant behaviors of these compounds are also evaluated with their influence upon the catalytic peroxidation of linoleic acid by the enzyme of lipoxygenase (LOX).
Results and discussion

General aspects
The reactions of bismuth(III) bromide with the heterocyclic thioamides (MMI: 2-mercapto-1-methylimidazole, MBZIM: 2-mercaptobenzimidazole, tHPMT: 2-mercapto-3,4,5,6-tetrahydro-pyrimidine, PYT: 2-mercaptopyridine, MBZT: 2-mercaptobenzothiazole) in 1:2 (M:L) molar ratio, 
Vibrational spectroscopy
The characteristic vibration bands of 1-5 and their ligands are summarized in Table S1 . Significant changes between (Ozturk et al., 2007 (Ozturk et al., , 2009 (Ozturk et al., , 2010 (Figures S6-S10) .
Further information about the bonding type of 1-5 was obtained by FT-Raman spectroscopy (Ozturk et al., 2007 (Ozturk et al., , 2009 (Ozturk et al., , 2010 (Ozturk et al., , 2011 (Ozturk et al., , 2012a (Ozturk et al., ,b, 2013 (Ozturk et al., , 2014a (Ozturk et al., ,b, 2017 Urgut et al., 2016a,b; Yarar et al., 2018) (Supplementary Table S1 , Figures S11-S15). The metal-sulfur vibration bands can be found between 200 and 350 cm −1 (Ozturk et al., 2007 (Ozturk et al., , 2009 (Ozturk et al., , 2010 (Ozturk et al., , 2011 (Ozturk et al., , 2012a (Ozturk et al., ,b, 2013 (Ozturk et al., , 2014a (Ozturk et al., ,b, 2017 Urgut et al., 2016a,b; Yarar et al., 2018) . The new peaks at 234 (1), 205 (2), 231 (3), 253 (4) and 228 cm −1 (5) are assigned at the Bi-S bond. The terminal Bi-Br vibration band appears at 187 (1), 148 (2), 162 (3), 165 (4) and 203 cm −1 (5), respectively. The bands at 168 (1), 142 (3), 145 (4) and 178 cm −1 (5) are attributed to the Bi-Br terminal bond. The bridging Bi-Br-Bi vibration bands for 1-5 appear at 105 (1), 108 (3), 117 (4) and 139 cm −1 (5), respectively. On the one hand, compound 2 is monomeric as the terminal Bi-Br and the Bi-S vibrations bands appeared in the Raman spectrum. Complexes 1, 3-5 on the other hand, have bridging Bi-Br-Bi vibration bands and terminal vibrations; therefore, they are classified as dimmers.
Given that the assignment of the vibrational spectra of 1-5 was made using the molecular structures, which were determined from the single crystal XRD data (see Section 'Crystal and molecular structures'), the retention of the formulae is deduced in the solid state for these samples. This is required for the samples' purity verification.
TG-DTA analysis
The thermal stability of 1-5 was analyzed by thermal gravimetry-differential thermal analysis (TG-DTA) under nitrogen atmosphere ( Figure S16 ). After the releasing of the solvents from the crystal lattice, complexes 1-5 are stable up to 206°C (1), 270°C (2), 150°C (3), 120°C (4) and 150°C (5), respectively. The corresponding TG-DTA diagrams for compounds 1-5 (206°C-940°C) (1), 100°C-825° C (2), 106°C-983°C (3), 110°C-983°C (4) and 128°C-983°C (5)) involve 100% (1), 98.91% (2), 97.95% (3), 100% (4) and 97.20% (5) mass losses, respectively.
UV-Vis spectroscopy
The UV-Vis absorption spectra of the heterocyclic thioamide ligands as well as the corresponding ones of their bismuth(III) bromide complexes 1-5 were recorded in the DMSO solution ( Figure S17 ). The absorption bands for complexes 1, 3 and 4 were observed around 300-450 nm, which can be attributed to the intra-ligand electrons' transitions. C NMR spectra of 1-5 showed the 1-3 ppm up-field shift for the C=S carbon due to complexation. Small shifts in the NMR spectra were also observed for antimony(III) complexes with thioamides or thiones (Ozturk et al., 2011 (Ozturk et al., , 2012a (Ozturk et al., ,b, 2013 (Ozturk et al., , 2014a (Ozturk et al., ,b, 2017 Urgut et al., 2016a,b; Yarar et al., 2018) .
NMR spectroscopy
The assignment of the NMR spectra in the solution was again made using the molecular structures (see Section 'Crystal and molecular structures'), and therefore, the retention of the formulae is deduced in the solutions. This is required for the further biological studies. Structural reports on bismuth(III) bromide complexes with ligands containing sulfur donor atoms (either thiones or thioureas) are already known Srinivas et al., 2015 Srinivas et al., , 2016 . Bismuth(III) bromide complexes with thione adopt octahedral (O h ), square pyramidal (SP) and pseudo-trigonal bipyramidal (ψ-TBP) geometries. The pseudo-trigonal bipyramidal bismuth(III) bromide complexes have a mononuclear core (e.g. [(IPr = S) BiBr 3 ] · CHCl 3 (Srinivas et al., 2015) ), while the octahedral and square pyramidal bismuth(III) bromide complexes have a binuclear core (e.g. (Srinivas et al., 2016) .
Crystal
Binuclear bismuth(III) complexes with octahedral geometry exhibit four different stereoisomers (Scheme 3), (a) those with two sulfur atoms and two halogen atoms in the cis-orientation and two bismuth atoms bridged to each other by two halogen atoms; (b) those with two sulfur atoms in the cis-position and two halogen atoms in transposition to each other, while the two bismuth atoms are bridged by two halogen atoms; (c) those with two sulfur atoms in the trans-position and two halogen atoms in the cis-position, while the two bismuth atoms are connected to each other by the two halogen bridges, (d) those with three halogen atoms in the meridional-position and two bismuth atoms, which are connected to each other by two sulfur bridges. However, the binuclear bismuth(III) bromide complexes with octahedral geometry reported up to now have cis-sulfur/trans halogen arrangements (Srinivas et al., 2016) .
The structures of 1-5 were determined by single crystal XRD. The selected interatomic distances (Å) and interatomic angles for 1-5 are reported in Table 1 Complex 1 is crystallized in the orthorhombic space group Cmc2 1 , 3 and 4 in the monoclinic space group C2/c and 5 in the triclinic space group P1 ̅ . Compounds 1, 3-5 are isostructural, while their structures constitute the first structurally characterized dinuclear bismuth(III) bromide derivatives with a bismuth:ligand ratio of 1:2. The complexes 1, 3-5 are dimeric with a center of inversion in the middle of the Bi 2 (μ-Br) 2 core in the solid state. The bismuth atoms expose a slightly distorted octahedral geometry. Each bismuth atom is coordinated by two sulfur atoms and four bromine atoms. Two of the bromine atoms are bridging while the other two bromine atoms are bound terminally to bismuth atoms.
The configuration of 1, 3 and 4 is cis-sulfur/transbromide arrangement, while the corresponding one of 5 is trans-sulfur/cis-bromide arrangement (Scheme 3). The crystal structure of 1, 3-5 is further stabilized by hydrogen bonding and weak electrostatic interactions (e.g. S · · · Br, S · · · S, C · · · C, C · · · H). These interactions make up a 3D supramolecular framework.
Complex 2 is a mononuclear ionic salt in the solid state and it is crystallized in monoclinic space group P2 1 /c. To the best of our knowledge, 2 is the first ionic mononuclear octahedral bismuth(III) bromide complex structurally characterized. The ionic compound contains the [BiS 4 Br 2 ]
+ cation, while a bromide serves as counter anion. The coordination number of bismuth in 2 is six, where the equatorial plane is setup by four sulfur atoms from the thione ligands, while the axial positions are occupied by two bromide ions. A third bromide counter ion neutralizes the complex. The basal interatomic angles in the cation are close to the ideal octahedral values. The neighbouring monomeric octahedral molecules are linked by hydrogen bonding and weak electrostatic interactions (e.g. Bi · · · Br, Br · · · S, C · · · C). Consequently, these bonding interactions lead to the 3D supramolecular framework.
The Bi-Br interatomic distances in 1-5 vary from 2.684(1) (Bi1-Br3(3)) to 3.117(1) (Bi1-Br1_a (5)) Å. These interatomic distances are in agreement with the corresponding interatomic distances observed in the known bismuth(III) bromide complexes Ozturk et al., 2014a,b; Srinivas et al., 2015 Srinivas et al., , 2016 . Similarly, the Bi-S interatomic distances vary from 2.707(3) (Bi1-S2A (3)) to 2.966(2) (Bi1-S1 (5)) Å in 1-5 The Bi-S interatomic distances are comparable with those found in the known bismuth(III) thione complexes Ozturk et al., 2014a,b; Srinivas et al., 2015 Srinivas et al., , 2016 Arda et al., 2016; Yarar et al., 2018) . The C=S interatomic distances in 1-5 vary from 1.678 (1) (5) 
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88.6(6) S1-Bi1-S2 90.8(7) Br3-Bi1-S2A 95.5(6) Br3-Bi1-S2A 78.9(7) Br3-Bi1-S3 92.6(5) Br3-Bi1-Br5 90.6(3) S1-Bi1-S2_a 89.1(7) Br3-Bi1- PYT: 1.692 Å and MBZT: 1.668 Å) (Ohms et al., 1982; Ravikuma et al., 1995; Popović et al., 2001; Lodochnikova et al., 2013) . They are, however, in the range of those measured in other antimony(III) halide compounds (Ozturk et al., 2007 (Ozturk et al., , 2009 (Ozturk et al., , 2010 . The C=S interatomic distance of the ligands suggests their coordination through their thionate forms.
Biological studies
The in vitro antiproliferative activities of 1-5 were tested against the human adenocarcinoma breast (MCF-7) and cervix (HeLa) cells by SRB assay after their incubation for 48 hrs.
Compounds 1-5, exhibit moderate activity against the adenocarcinoma cells. The IC 50 values of 4 against HeLa and MCF-7 cells are 6.5 ± 0.7 μM and 9.7 ± 1.0 μM respectively (Table 2) . Therefore, the coordination of PYT enhances its biological activity. On the contrary, this is not observed when the rest of the ligands were used. Similarly, when bismuth(III) chloride complexes of the same thioamides (Yarar et al., 2018) were tested against the same cell lines, the corresponding one of the PYT exhibits the stronger activity once again. Among the bismuth(III) halide compounds of the thioamides tested (Table 2) against the HeLa and MCF-7 cells, a stronger activity is observed for the {[BiCl 3 (μ 2 -S-PYT)(PYT)] 2 }. A stronger activity of 4-5 has also been detected against HeLa than MCF-7 cells. The IC 50 values of 5 are 15.0 ± 1.1 μM and >30 μM, against the HeLa and MCF-7 cells, respectively. However, the cisplatin exhibits higher activity against the HeLa and MCF-7 cells than the study compounds 1-5. The IC 50 values of the ligands are higher than 30 μμ against the MCF-7 and HeLa cells.
The toxicities of 1-5 were studied against the non-cancerous cells MRC-5. The IC 50 values of 1-3, 5 are higher than 30 μM, indicating non = toxic behavior. However, the IC 50 value of 4 against MRC-5 is 7.1 ± 0.6 μM, which is close to the corresponding one found against the HeLa and MCF-7 cells (6.5 ± 0.7 and 9.7 ± 1.0 μM, respectively) ( Table 2 ). The therapeutic potency indexes (TPI=IC 50 (normal cells)/ IC 50 (tumor cells) of 4 are 1.1 and 0.7 for the HeLa and MCF-7 cells respectively. In addition, 1-5 exhibit lower toxicity than cisplatin (IC 50 = 1.1 ± 0.2 μM). The IC 50 values of the ligands against the MRC-5 cells are higher than 30 μM.
In comparison, the bismuth(III)-dithiocarbamate complexes exhibit a significantly higher activity against both the HeLa and MCF-7 cells (Table 2) . Their IC 50 values lie between 0.023 and 0.33 μM (Yarar et al., 2018) .
Study of the peroxidation of the linoleic acid by the enzyme lipoxygenase in the presence of bismuth(III) bromide complexes 1-5 and free thiomide ligands
LOXs are a group of oxidative enzymes with a non-heme iron atom in their active site (Haining and Axelrod, 1958; Knapp and Klinman, 2003) ; they are often associated with tumor cell proliferation, differentiation and apoptosis (Samuelsson et al., 1987) . Some evidence have proven the crucial role of LOX in cancer (Poyraz et al., 2011; Banti et al., 2016) as its inhibition induces apoptosis . The degree of LOX activity (A, %) in the presence of 1-5 was calculated according to the method described previously (Xanthopoulou et al., 2008; Ozturk et al., 2010; Poyraz et al., 2011) . The effects of 1-5 and free thioamide ligands upon the oxidation of linoleic acid by the enzyme LOX were studied in a wide concentration range ( Figure 6 ). The IC 50 values of 1-5 are 66.73 (1), 48.83 (2), 65.27 (3), 176.80 (4) and 48.58 μM (5), and for their free ligands, 377 (MMI), 286 (MBZIM), 219 (tHPMT), 1796 (PYT) and 188.3 μM (MBZT), respectively ( Figure 7 ). The Bi(III) complexes 1-5 inhibit LOX activity in a moderate manner, which is in agreement with the antiproliferative studies as the compounds possess low cytotoxic activity. The IC 50 values of bromide bismuth(III) complexes against LOX are in accordance with the corresponding ones of their chloride analogues (Figure 7) . Although 1-5 exhibit inhibitory activity against LOX; however, this is lower than the corresponding one of the organotin(IV) or silver(I) complexes (Xanthopoulou et al., 2008; Banti et al., 2016) . This activity follows the relatively low cytotoxicity of these complexes.
Conclusions
In conclusion, five novel bismuth(III) bromide complexes with heterocyclic thioamide ligands have been successfully synthesized and characterized. (5) show versatile coordination modes. The molecular structures of complexes 1, 3, 4 and 5 are isostructural. These are the first examples of dinuclear bismuth(III) bromide compounds that have been structurally characterized with square pyramidal (SP) conformation around the metal center. The secondary Bi · · ·(μ 2 -Br) bonding interactions developed in 1, 3, 4 and 5 lead to octahedral arrangement (Oh). Moreover, the molecular structure of compound 2 is unique as it is the first ionic mononuclear octahedral bismuth(III) bromide complex.
Furthermore, the in vitro antiproliferative activity of 1-5 was tested against human adenocarcinoma breast (MCF-7) and cervix (HeLa) cells. Between the bromide compounds tested here, {[BiBr 2 (μ 2 -Br)(PYT) 2 ] 2 · CH 3 CN} (4) exhibits the lower IC 50 values (stronger activity) against cells, which is comparable to the corresponding chloride ones (Table 2) . Among the bismuth bromides and chloride complexes, those of 2-mercapto-pyridine 4 and {[BiCl 3 (μ 2 -S-PYT)(PYT)] 2 } exhibit the strongest such activity (Table 2) . Therefore, PYT enhances the biological activity, although the formation of octahedral arrangement around the metal centers is formed either by μ 2 -Br or μ 2 -S-PYT secondary binding interactions. Furthermore, bismuth(III) compounds with dithiocarbamates exhibit significantly higher activity than those of heterocyclic thioamides, which in case of {[BiCl(Me 2 DTC) 2 ] n }, increase even up to 250-fold than the corresponding one of cisplatin (Table 2 ). The inhibitory activity of the bromides or chloride bismuth(III) compounds against LOX follows their corresponding antiproliferative behaviour, thus confirming our assumption that this inhibition might be used as an indicator for the antiproliferative potential of a formulation (Xanthopoulou et al., 2008; Poyraz et al., 2011; Banti et al., 2016) . In conclusion, based on the cell antiproliferative studies presented here, more efficient Bi(III) metallodrugs should be designed in the future within the class of dithiocarbamate ligands.
Experimental Materials and instruments
All solvents used were of reagent grade. Bismuth(III) bromide (Merck, Darmstadt, Germany) and the 2-mercapto-1-methyl-imidazolidine (Sigma), 2-mercapto-benzimidazole (Merck, Darmstadt, Germany), 2-mercapto-3,4,5,6-tetrahydro-pyrimidine (Merck Darmstadt, Germany), 2-mercapto-pyridine (Merck, Darmstadt, Germany) and 2-mercapto-benzothiazole (Merck, Darmstadt, Germany) were used without further purification. The elemental analyses for C, H, N, and S were carried out with a Carlo Erba EA MODEL 1108 elemental analyzer (Milan, Italy). The melting points were measured in open tubes with a STUART SMP30 (Stone, Staffordshire, UK) scientific apparatus and were left uncorrected. The FT-IR spectra were recorded in the 4000-400 cm −1 region with Bruker Optics, Vertex 70 FT-IR spectrometer (Ettlingen, Germany) using ATR techniques. The far IR absorption spectra were recorded in 400-50 cm −1 using the FT-IR Bruker Equinox 55 spectrometer equipped with a Bruker Hyperion 1000 microscope (Ettlingen, Germany). Micro Raman spectra (64 scans) were recorded at room temperature using a low-power (~30 mW) green (514.5) mm laser on a Renishaw In Via spectrometer set at 2.0 resolution. The ) with a heating rate of 10°C min −1 . The UV spectra were recorded in a Shimadzu UV-2600 UVVis spectrophotometer (Kyoto, Japan).
Synthesis and crystallization of the compounds
The {[BiBr 2 (μ 2 -Br)(MMI) 2 ] 2 · CH 3 COCH 3 · H 2 O} (1): 0.25 mmol bismuth(III) bromide (0.112 g) and 0.50 mmol 2-mercapto-1-methylimidazole (0.057 g) were dissolved in 10 mL acetone, respectively. The resulting solution was stirred at room temperature for 4 h. The 
X-ray structure determination
Single crystal XRD diffraction data for 1, 2 and 5 were collected on an Oxford-Diffraction Supernova diffractometer, equipped with a CCD area detector utilizing Cu Kα (λ = 1.5418 Å) radiation. A suitable crystal was mounted on a Hampton cryoloop with Paratone-N oil and transferred to a goniostat where it was cooled for data collection. The empirical absorption corrections (multiscan based on symmetry-related measurements) were applied using the CrysAlis RED software (Oxford-Diffraction). The structures were solved by direct methods using the SIR2004 (Burla et al., 2005) and refined on F 2 using the full-matrix least-squares with SHELXL-2014/7 (Sheldrick, 2014). The software packages used were as follows: CrysAlis CCD for data collection (Oxford Diffraction) CrysAlis RED for cell refinement and data reduction (Oxford Diffraction) WINGX for geometric calculations (Farrugia, 1999) and ORTEP for molecular graphics. The non-H atoms were treated anisotropically, whereas the aromatic H atoms were placed in calculated, ideal positions and refined as riding on their respective carbon atoms. Crystal data for 3 and 4 were measured on a KUMA KM4CCD four-circle diffractometer (CrysAlis CCD) equipped with a CCD detector using the graphite-monochromated MoKa radiation (λ = 0.71073 Å). Cell parameters were determined by the least-squares refinement of the diffraction data from 25 reflections (CRYSALIS RED). All data were corrected for the Lorentz-polarization effects and absorption (CRYSALIS RED; Sheldrick, 1990) . The structures were solved with direct methods with SHELXS97 (Sheldrick, 1990 ) and refined by full-matrix leastsquares procedures on F 2 with SHELXL97 (Sheldrick, 1997) . All nonhydrogen atoms were refined anisotropically. The hydrogen atoms were located at the calculated positions and then refined via the 'riding model' with isotropic thermal parameters fixed at 1.2 (1.3 for CH 3 groups). The experimental crystallographic data for 1-5 are provided in Table 3 . The structure determination of 2 and 5 ended up in quite large R-factors. This is due to twin crystals. However, despite the high R-factors, the refinement of the data resulted in the safe formulae for these compounds. These are then used for the solution preparation for the biological experiments, which is the main aim of this work.
Supplementary data are available from CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (e-mail: mailto:deposit@ccdc.cam.ac.uk), on request, quoting the deposition numbers CCDC 1831830 (1), 1831829 (2), 1832427 (3), 1832428 (4) and 1831828 (5).
Biological tests
Biological experiments were carried in dimethyl sulfoxide Dulbecco's Modified Eagle's Medium solutions (DMEM) DMSO/DMEM (0.02%-0.2% v/v) for the complexes 1-5. The stock solutions of the complexes 1-5, (0.01 m) in DMSO were freshly prepared and diluted in a cell culture medium to the desired concentrations (0.5-30 μm). The results are expressed in terms of IC 50 values, that is, the concentration of drug required to inhibit cell growth by 50% compared to control, after of 48 h incubation of the complexes towards cell lines. The cell viability was determined by SRB assay, as previously described .
Lipoxygenase activity inhibition
This was performed as previously reported (Xanthopoulou et al., 2008) .
